Poornima Sood, MD

Poornima Sood, MD, joined Abiomed in April 2022 as vice president, global clinical and regulatory affairs. She is a passionate clinical trialist who thrives on working with her team to generate compliant clinical data of the highest quality to help Abiomed’s cutting edge products get to market for the benefit of patients. She is a strategic leader who believes in individual leadership and building a strong and thriving organizational culture.

Poornima grew up in Mumbai, India, where she trained as a physician at GS Medical College and King Edward Memorial Hospital. She specialized in cardiovascular pharmacology at the University of Cambridge in the United Kingdom. She also holds an MBA in healthcare management.

After moving to California in 2000, Poornima began her MedTech career at Guidant/Abbott Vascular where she held several leadership roles and led regulatory approval of the XIENCE V drug eluting stent. She joined Thoratec Corp (subsequently acquired by St Jude Medical/Abbott) as senior director, clinical affairs and later senior director, global clinical and regulatory affairs. During this time, she led many successful clinical studies and regulatory approvals, the most significant being the approval globally of the HeartMate 3 LVAD.